Contract dispute could impact thousands needing medical attention
Bon Secours and UnitedHealthcare have a contact that is set to expire July 1. Both said they are at opposite ends of the bargaining table, requiring to continue working with each other.
Come July 1, if an agreement is not reached between the companies, the two will no longer continue services as part of an in-network option for patients. This would mean if patients still wanted to see there Bon Secours doctor under UnitedHealthcare's insurance, they could, but would pay out-of-pocket and at a much higher cost.
Bon Secours said they have been in negotiations since January, and around 30,000 patients will be impacted if an agreement is not reached.
Both companies said the other is asking too much.
'We've made repeated efforts to secure a fair agreement that reflects today's health care environment, but UnitedHealthcare continues to underpay compared to market standards,' said Matt Caldwell, President, Bon Secours Greenville market.
Bon Secours said they are working towards an agreement that would allow them to continue providing high quality care to patients, but UnitedHealthcare said that the rate they are asking them to pay them is too high.
'Bon Secours St. Francis is seeking a price increase of nearly 32% for our commercial plans over the next three years, along with a substantial rate hike for our Medicare Advantage plans, which would make them the most expensive in our South Carolina network.' said Trasee Carr, Corporate Communications with UnitedHealthcare.
Through four months of negotiations, both companies state they are only looking out for the best interest of their patients.
'We are committed to doing everything possible to avoid any network disruption,' said officials at Bon Secours.
They called out UnitedHealthcare, saying their unwillingness to collaborate threatens to disrupt care for thousands of patients.
'Our top priority is to reach an agreement that remains affordable and ensures continued access to the health system,' UnitedHealthcare responded. 'We hope Bon Secours St. Francis shares our commitment and collaborates on solutions that South Carolina families and employers can afford.'
At this time, it is unclear if either party is willing to come closer to fulfilling what the other is asking of them.
UnitedHealthcare tells us they proposed an offer to Bon Secours to extend their current contract through July if negotiations are still ongoing, however they said Bon Secours refused that offer.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
a day ago
- Business Insider
With UnitedHealth Group (UNH) Stock Down Over 50%, Let's Look at Who Owns It
UnitedHealth Group (UNH) has had a rough ride in 2025. The stock is down over 56% year-to-date, hit by rising medical costs, a DOJ probe, executive changes, and now disappointing Q2 results. The company recently posted adjusted earnings per share of $4.08 on $111.6 billion in revenue, narrowly beating the revenue forecast but missing the EPS consensus of around $4.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Still, the company reaffirmed its full-year guidance and provided more clarity on its 2025–2026 outlook, prompting mixed reactions from analysts. For instance, analyst Lance Wilkes from Bernstein remains optimistic, citing UnitedHealth's strong market position and potential rebound in Medicare Advantage trends. In contrast, BofA analyst Kevin Fischbeck is more cautious, due to concerns over the company's slower growth pace. With the stock in focus, now's a good time to take a closer look at who actually owns UNH shares. Now, according to TipRanks' ownership page, public companies and individual investors own 45.60% of UNH. They are followed by mutual funds, ETFs, other institutional investors, and insiders at 28.84%, 23.20%, 2.19%, and 0.18%, respectively. Digging Deeper into UnitedHealth Group's Ownership Structure Looking closely at top shareholders, Vanguard owns the highest stake in UNH at 8.89%. Next up is Vanguard Index Funds, which holds a 7.03% stake in the company. Among the top ETF holders, the Vanguard Total Stock Market ETF (VTI) owns a 3.22% stake in UNH stock, followed by the Vanguard S&P 500 ETF (VOO), with a 2.84% stake. Moving to mutual funds, Vanguard Index Funds holds about 7.03% of UNH. Meanwhile, Fidelity Concord Street Trust owns 1.72% of the company. Is UNH a Good Buy Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, three Holds, and two Sells assigned in the last three months. At $321.76, the average UnitedHealth stock price target implies a 28.93% upside potential.
Yahoo
2 days ago
- Yahoo
An Unpopular Pick: 5 Reasons Why Buying UnitedHealth Group Stock Now Could Be a Brilliant Move
Key Points UnitedHealth Group continues to face multiple challenges. The company has a plan to address the issues and boost its bottom line. The stock is a bargain with solid long-term growth prospects. 10 stocks we like better than UnitedHealth Group › An old country song morbidly titled "Gloom, Despair, and Agony on Me" included the lyrics, "If it weren't for bad luck, I'd have no luck at all." This might be an apt motto for UnitedHealth Group (NYSE: UNH) these days. The healthcare giant continued to disappoint investors with its 2025 second-quarter update, revealing that full-year earnings will be worse than expected. The U.S. Department of Justice (DOJ) is conducting an investigation of UnitedHealth related to its Medicare billing practices, and its share price has plunged nearly 60% from the peak set in late 2024. UnitedHealth Group stock is a decidedly unpopular pick. However, here are five reasons why buying this beaten-down stock could be a brilliant move. 1. The company has a plan to address its problems It would be one thing if UnitedHealth Group's challenges were insurmountable, but they're not. The company has a clear and compelling plan to address its problems. UnitedHealth didn't anticipate how hard it would be hit by rising medical costs, especially with its Medicare Advantage plans. The most effective solution to this issue is simple: Raise premiums. That's exactly what UnitedHealth plans to do, but it has to wait until the beginning of next year for most premium hikes to take effect. Since commercial plans renew throughout the year, the company can implement premium changes more quickly with this line of business. Tim Noel, the new CEO of the UnitedHealthcare insurance business, said in the Q2 earnings call that his unit will have "strongly responsive pricing for 2026." That's not the only step the company is taking, though. Noel stated that UnitedHealthcare has "stepped up our audit clinical policy and payment integrity tools to protect customers and patients from unnecessary costs." He added that the business is also streamlining its provider networks, especially for Medicare Advantage plans. UnitedHealth Group's Optum segment isn't performing as well as desired, either. Again, though, the company is implementing a plan to fix the problems. Optum CEO Patrick Conway said in the Q2 call that price increases are coming to reflect high patient acuity and risk. He also mentioned that Optum Health will discontinue serving around 200,000 patients. 2. Cost-cutting should boost the bottom line UnitedHealth Group is also moving forward with cost-cutting initiatives to boost its bottom line. CEO Stephen Hemsley referred to "meaningful cost opportunities within the enterprise" in his comments during the Q2 call, adding, "[W]e are pursuing them with urgency." Noel highlighted his unit's efforts to scale artificial intelligence (AI) across health plan operations, which should generate cost savings while improving patient and provider experiences. Conway expects Optum Health to deliver nearly $1 billion in cost savings in 2026. 3. Long-term growth prospects remain strong Despite UnitedHealth's challenges over the near term, its long-term growth prospects remain strong. The company expects to return to earnings growth next year. Hemsley predicts that earnings growth will accelerate in 2027 and beyond. Is this upbeat assessment merely the result of a CEO looking through rose-colored glasses? I don't think so. The consensus among analysts surveyed by LSEG is that UnitedHealth Group will deliver solid year-over-year earnings growth in 2026. 4. An experienced, steady hand is now at the wheel It's also important for investors to remember that UnitedHealth Group once again has an experienced, steady hand at the wheel. Hemsley returned to run the company two months ago. He previously served as CEO from 2006 to 2017, a period during which UnitedHealth Group flourished and its share price soared. 5. The stock is a bargain Last, but not least, UnitedHealth Group stock is a bargain. Its shares trade at a forward price-to-earnings ratio of below 11.6. That's not much higher than the valuation during the financial crisis of 2008 and 2009. Does the DOJ investigation justify such a low earnings multiple? I don't think so. UnitedHealth survived a previous lengthy investigation, with a court-appointed Special Master ultimately concluding that there wasn't evidence that the company had done anything wrong. Independent audits from the Centers for Medicare and Medicaid Services show that UnitedHealth's Medicare practices are, in the company's words, "among the most accurate in the industry." UnitedHealth Group insists that it "has full confidence in its practices." Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $630,291!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,075,791!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. An Unpopular Pick: 5 Reasons Why Buying UnitedHealth Group Stock Now Could Be a Brilliant Move was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
UnitedHealth Group appoints new CFO in wake of top leadership change
After a year that has seen its share price collapse by more than 50%, UnitedHealth Group (UNH) has swapped out its chief financial officer. Wayne DeVeydt will take over as CFO of UnitedHealth effective Sept. 2, according to securities filings. He replaces John Rex, who has been in the role since 2016. Shares of UnitedHealth dropped around .60% early Friday. The move, announced Thursday night, follows UnitedHealth founder and executive chairman Stephen Hemsley taking back the reins following CEO Andrew Witty's sudden departure in May. Rex will transition from CFO to strategic adviser to the CEO, a move that UnitedHealth said in filings was arranged in Rex's 2016 employment contract. "Given the downward revisions to estimates in the past six months, the return of CEO Stephen Hemsley, and the extensive management changes made across UNH, we appreciate the desire to make a change at CFO," JPMorgan analyst Lisa Gill wrote in a note. Read more: What is a healthcare FSA and how can it help you save on medical costs? DeVeydt is joining an insurance giant under pressure. In its earnings release this week, UnitedHealth reported its highest-ever medical loss ratio (MLR), at 89.4%, highlighting the company's cost pressures. MLR is the ratio of claims paid versus revenue from premiums received; the Affordable Care Act defines good management as a window between 80% and 85%. The company reported higher revenues than Wall Street expectations, $111.6 billion compared to estimates of $111.53 billion. UnitedHealth missed on earnings per share, reporting $4.08 compared to Street expectations of $4.59. The company had previously slashed its annual forecast in April after its medical care costs came in higher than expected, sending shares down by 22% in UnitedHealth's biggest drop in a single day since 1998. In May, UnitedHealth had contributed to 88% of the Dow's decline in the past year. UnitedHealth is also currently facing a criminal and civil investigation by the Department of Justice over potential fraudulent billing practices in its Medicare Advantage program. DeVeydt was most recently an operating partner at private equity giant Bain Capital and was previously executive chair of surgical operator Surgery Partners. CEO Hemsley said on an earnings call this week that over the past two months, the company has "made extensive management and operational changes" to align with its agenda of reform and performance. "Other such changes — to our leadership, to our businesses, our culture, approaches, and practices, and to our board, governance, and succession oversight, as appropriate, will continue to be made as we proceed through this period," he said. Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at
